Literature DB >> 15052605

Amelioration of sulfur mustard skin injury following a topical treatment with a mixture of a steroid and a NSAID.

Shlomit Dachir1, Eliezer Fishbeine, Yakov Meshulam, Rita Sahar, Shira Chapman, Adina Amir, Tamar Kadar.   

Abstract

The ability to ameliorate sulfur mustard (HD)-induced oedema by treatment with anti-inflammatory drugs was reported previously after screening four steroids and four non-steroidal anti-inflammatory drugs (NSAIDs) using the mouse ear vesicant model. Following the screening study, one steroid and one NSAID (Adexone and Voltaren) were selected as the most effective, and a mixture of the two was chosen for the present more extensive research. The effect of the combined treatment on clinical, biochemical and histopathological parameters following HD insult was studied. Mice ears were exposed to 0.2 micro l of HD for 10 min to produce a moderate skin injury. Oedema development peaked ca. 48 h following exposure, as determined by weighing ear biopsies. Histological observations at that time exhibited damage to the epidermis and dermis. An increase in prostaglandin E (PGE) was measured in skin homogenates, starting 8 h following exposure and lasting at least up to 48 h post-exposure. A topical treatment using the above anti-inflammatory mixture significantly reduced inflammatory parameters when applied up to 4 h following exposure. These parameters included extent of oedema, levels of PGE, area of clinical damage and extent of cytotoxic injury (vesications and damaged epithelial cells). Thus, a combination of a steroid and NSAID was found to be effective in reducing the intensity of HD skin injury and possibly shortening the time to full recovery. The treatment, however, did not prevent completely the ensuing cytotoxic processes in the epithelial layer. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15052605     DOI: 10.1002/jat.955

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  10 in total

1.  Investigation of anticholinergic and non-steroidal anti-inflammatory prodrugs which reduce chemically induced skin inflammation.

Authors:  Sherri C Young; Karine M Fabio; Mou-Tuan Huang; Jaya Saxena; Meredith P Harman; Christophe D Guillon; Anna M Vetrano; Diane E Heck; Robert A Flowers; Ned D Heindel; Jeffrey D Laskin
Journal:  J Appl Toxicol       Date:  2011-02-11       Impact factor: 3.446

2.  Role of MAP kinases in regulating expression of antioxidants and inflammatory mediators in mouse keratinocytes following exposure to the half mustard, 2-chloroethyl ethyl sulfide.

Authors:  Adrienne T Black; Laurie B Joseph; Robert P Casillas; Diane E Heck; Donald R Gerecke; Patrick J Sinko; Debra L Laskin; Jeffrey D Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2010-04-09       Impact factor: 4.219

Review 3.  Corneal toxicity induced by vesicating agents and effective treatment options.

Authors:  Dinesh G Goswami; Neera Tewari-Singh; Rajesh Agarwal
Journal:  Ann N Y Acad Sci       Date:  2016-06-21       Impact factor: 5.691

4.  Expression of proliferative and inflammatory markers in a full-thickness human skin equivalent following exposure to the model sulfur mustard vesicant, 2-chloroethyl ethyl sulfide.

Authors:  Adrienne T Black; Patrick J Hayden; Robert P Casillas; Diane E Heck; Donald R Gerecke; Patrick J Sinko; Debra L Laskin; Jeffrey D Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2010-09-16       Impact factor: 4.219

5.  Flavanone silibinin treatment attenuates nitrogen mustard-induced toxic effects in mouse skin.

Authors:  Anil K Jain; Neera Tewari-Singh; Swetha Inturi; Dileep Kumar; David J Orlicky; Chapla Agarwal; Carl W White; Rajesh Agarwal
Journal:  Toxicol Appl Pharmacol       Date:  2015-03-16       Impact factor: 4.219

Review 6.  Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure.

Authors:  Michael P Shakarjian; Diane E Heck; Joshua P Gray; Patrick J Sinko; Marion K Gordon; Robert P Casillas; Ned D Heindel; Donald R Gerecke; Debra L Laskin; Jeffrey D Laskin
Journal:  Toxicol Sci       Date:  2009-10-15       Impact factor: 4.849

7.  Analgesic and anti-inflammatory activity of amifostine, DRDE-07, and their analogs, in mice.

Authors:  Yangchen Doma Bhutia; Rajagopalan Vijayaraghavan; Uma Pathak
Journal:  Indian J Pharmacol       Date:  2010-02       Impact factor: 1.200

Review 8.  The possible role of intravenous lipid emulsion in the treatment of chemical warfare agent poisoning.

Authors:  Arik Eisenkraft; Avshalom Falk
Journal:  Toxicol Rep       Date:  2016-01-18

9.  Sulfur mustard research--strategies for the development of improved medical therapy.

Authors:  Kai Kehe; Frank Balszuweit; Judith Emmler; Helmut Kreppel; Marianne Jochum; Horst Thiermann
Journal:  Eplasty       Date:  2008-06-10

10.  A Novel Topical Ophthalmic Formulation to Mitigate Acute Mustard Gas Keratopathy In Vivo: A Pilot Study.

Authors:  Ratnakar Tripathi; Praveen K Balne; Nishant R Sinha; Lynn M Martin; Sabeeh Kamil; James R Landreneau; Suneel Gupta; Jason T Rodier; Prashant R Sinha; Nathan P Hesemann; Alexandria C Hofmann; Michael K Fink; Shyam S Chaurasia; Rajiv R Mohan
Journal:  Transl Vis Sci Technol       Date:  2020-11-02       Impact factor: 3.283

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.